Heme: A regulator of rat hepatic tryptophan 2,3-dioxygenase?

被引:62
|
作者
Ren, SY
Correia, MA
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA
关键词
tryptophan 2,3-dioxygenase; hepatic heme depletion; heme regulation; 3,5-dicarbethoxy 2,6-dimethyl-4-ethyl-1,4-dihydropyridine; de novo synthesis; dexamethasone induction;
D O I
10.1006/abbi.2000.1755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hepatic cytosolic hemoprotein tryptophan 2,3-dioxygenase (TDO) is the rate-limiting enzyme in tryptophan catabolism and thus plays a key role in regulating the physiological flux of tryptophan into relevant metabolic pathways. The TDO protein is induced by corticosteroids such as dexamethasone (DEX) and is stabilized by its prosthetic heme, In rats, acute chemically induced hepatic heme depletion reduces the functional hepatic TDO levels to 25-30% of basal levels within 1 h, and this decrease persists beyond 28 h of heme depletion at which time only 25-30% of the protein is available for heme incorporation. Since this could stem from impaired de novo synthesis and/or instability of the newly synthesized apoTDO protein in the absence of heme, we examined the specific role of heme in these events in a previously validated rat model of acute hepatic heme depletion triggered by the P450 suicide substrate 3,5-dicarbethoxy 2,6-dimethyl-4-ethyl-1,4-dihydropyridine. We now show that exogenous heme can reverse the functional impairment of the enzyme observed during hepatic heme depletion and fully restore the impaired DEX-mediated induction of the enzyme to normal. Furthermore, through Northern/slot blot analyses coupled with nuclear run-on studies, we now document that this heme regulation of TDO is exerted primarily at the transcriptional level. Immunoblotting analyses also reveal corresponding changes in the TDO protein, thereby establishing that heme is necessary for DEX-inducible TDO mRNA transcription and subsequent translation. Thus, the TDO gene may contain heme-regulatory elements in addition to the reported glucocorticoid-responsive elements. Together, these findings suggest that clinically, hepatic heme deficiency may enhance the tryptophan flux into synthetic (serotonergic) pathways, not only by depriving prosthetic heme for a functionally competent TDO hemoprotein, its primary catabolic enzyme, but also by impairing the de novo synthesis of this enzyme. (C) 2000 Academic Press.
引用
收藏
页码:195 / 203
页数:9
相关论文
共 50 条
  • [41] Antitumour agents as inhibitors of tryptophan 2,3-dioxygenase
    Pantouris, Georgios
    Mowat, Christopher G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (01) : 28 - 31
  • [42] CONVENIENT AND SENSITIVE ASSAY FOR TRYPTOPHAN 2,3-DIOXYGENASE
    METZLER, H
    GEBHARDT, R
    OBERRAUCH, W
    MECKE, D
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1980, 361 (03): : 302 - 303
  • [43] TRYPTOPHAN 2,3-DIOXYGENASE IN SACCHAROMYCES-CEREVISIAE
    IWAMOTO, Y
    LEE, ISM
    TSUBAKI, M
    KIDO, R
    CANADIAN JOURNAL OF MICROBIOLOGY, 1995, 41 (01) : 19 - 26
  • [44] Hypertryptophanemia due to tryptophan 2,3-dioxygenase deficiency
    Ferreira, Patrick
    Shin, Inchul
    Sosova, Iveta
    Dornevil, Kednerlin
    Jain, Shailly
    Dewey, Deborah
    Liu, Fange
    Liu, Aimin
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (04) : 317 - 324
  • [45] Inhibitory effect of ascorbate on tryptophan 2,3-dioxygenase
    Yuasa, Hajime Julie
    JOURNAL OF BIOCHEMISTRY, 2022, 171 (06): : 653 - 661
  • [46] INHIBITION OF INDOLEAMINE 2,3-DIOXYGENASE AND TRYPTOPHAN 2,3-DIOXYGENASE BY BETA-CARBOLINE AND INDOLE-DERIVATIVES
    EGUCHI, N
    WATANABE, Y
    KAWANISHI, K
    HASHIMOTO, Y
    HAYAISHI, O
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 232 (02) : 602 - 609
  • [47] Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase
    Li, Yuanyuan
    Zhang, Shengnan
    Wang, Rong
    Cui, Menghan
    Liu, Wei
    Yang, Qing
    Kuang, Chunxiang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (11)
  • [48] 2,5-DIHYDRO-L-PHENYLALANINE - COMPETITIVE INHIBITOR OF INDOLEAMINE 2,3-DIOXYGENASE AND TRYPTOPHAN 2,3-DIOXYGENASE
    WATANABE, Y
    FUJIWARA, M
    HAYAISHI, O
    TAKEUCHI, T
    UMEZAWA, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 85 (01) : 273 - 279
  • [49] INOR 760-Alternative mechanisms for indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO): A DFT study on a missing piece in understanding of heme chemistry
    Chung, Lung Wa
    Li, Xin
    Sugimoto, Hiroshi
    Shiro, Yoshitsugu
    Morokuma, Keiji
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [50] Subunit structure of recombinant rat liver L-tryptophan 2,3-dioxygenase
    Manandhar, SP
    Shimada, H
    Nagano, S
    Egawa, T
    Ishimura, Y
    OXYGEN AND LIFE: OXYGENASES, OXIDASE AND LIPID MEDIATORS, 2002, 1233 : 161 - 169